According to the Complaint, on or about June 6, 2014, Revance filed with the SEC its registration statement, which, following amendment and being declared effective by the SEC on June 18, 2014, would later be utilized for the Offering. The Complaint alleges the Registration Statement was negligently prepared and, as a result, contained untrue statements of material facts or omitted to state other facts necessary to make the statements made not misleading, and was not prepared in accordance with the rules and regulations governing its preparation.
On August 31, 2015, the Court issued an Order granting Plaintiff's motion to remand to the Superior Court of the State of California for the County of San Mateo.
Company & Securities Information
Defendant: Revance Therapeutics, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: RVNC
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
City of Warren Police and Fire Retirement System, et al. v. Revance Therapeutics, Inc., et al.